Bismarck E, Schmitz-Dräger B J, Schöffski O
Urologie, EuromedClinic und Urologie24, c/o Europa-Allee 1, 90763, Fürth, Deutschland.
Urologe A. 2012 Apr;51(4):533-8. doi: 10.1007/s00120-011-2778-1.
Medicine has changed dramatically in the past ten decades thanks to the introduction of innovative diagnostic and therapeutic procedures. However, besides the unmistakable advances achieved in medicine, the costs of all health care systems have risen dramatically. In contrast to the escalation in expenditures, only moderate gains in proceeds have been accomplished. This situation requires that future financial resources be judiciously expended. The field of health economics has set as its goal the analysis of medical measures in terms of costs and benefits to be able to provide information on these parameters to those involved in the public health sector. The emerging problems are diverse and extend from assessment of effects and side effects to difficulties in standardizing analytical procedures and comparing results between different health care systems.In the context of this manuscript an attempt has been made to illustrate the methodological approaches to health economics based on current issues in the diagnosis and treatment of prostate cancer. This contribution intends to motivate stakeholders to view health economics as a tool to promote improvements in medical care and not as a means to regulating and rationing medical measures.
在过去的一个世纪里,由于创新诊断和治疗程序的引入,医学发生了巨大变化。然而,除了医学取得的明显进步外,所有医疗保健系统的成本也大幅上升。与支出的增加形成对比的是,收入仅实现了适度增长。这种情况要求未来的财政资源得到明智的使用。卫生经济学领域的目标是从成本和效益方面分析医疗措施,以便能够向公共卫生部门的相关人员提供这些参数的信息。新出现的问题多种多样,从评估效果和副作用到标准化分析程序和比较不同医疗保健系统之间的结果的困难。在本手稿中,试图根据前列腺癌诊断和治疗中的当前问题来说明卫生经济学的方法。这一贡献旨在激励利益相关者将卫生经济学视为促进医疗保健改善的工具,而不是作为规范和配给医疗措施的手段。